These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 19163949)

  • 21. Systemically modeling the dynamics of plasma insulin in subcutaneous injection of insulin analogues for type 1 diabetes.
    Li J; Kuang Y
    Math Biosci Eng; 2009 Jan; 6(1):41-58. PubMed ID: 19292507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fuzzy-based controller for glucose regulation in type-1 diabetic patients by subcutaneous route.
    Campos-Delgado DU; Hernández-Ordoñez M; Femat R; Gordillo-Moscoso A
    IEEE Trans Biomed Eng; 2006 Nov; 53(11):2201-10. PubMed ID: 17073325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-Validation of a Glucose-Insulin-Glucagon Pharmacodynamics Model for Simulation Using Data From Patients With Type 1 Diabetes.
    Wendt SL; Ranjan A; Møller JK; Schmidt S; Knudsen CB; Holst JJ; Madsbad S; Madsen H; Nørgaard K; Jørgensen JB
    J Diabetes Sci Technol; 2017 Nov; 11(6):1101-1111. PubMed ID: 28654314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Glucose metabolism modeling of diabetes patients with different intensities of aerobic exercise: an in silico study].
    Jin J; Yu L; Jin Z
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2019 Apr; 36(2):274-280. PubMed ID: 31016945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin glargine: cornerstone treatment for type 2 diabetes patients. Introduction.
    Garg SK
    Diabetes Obes Metab; 2008 Jul; 10 Suppl 2():1-4. PubMed ID: 18577151
    [No Abstract]   [Full Text] [Related]  

  • 26. Beneficial effects of addition of oral spray insulin (Oralin) on insulin secretion and metabolic control in subjects with type 2 diabetes mellitus suboptimally controlled on oral hypoglycemic agents.
    Guevara-Aguirre J; Guevara M; Saavedra J; Mihic M; Modi P
    Diabetes Technol Ther; 2004 Feb; 6(1):1-8. PubMed ID: 15000763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preliminary experience of the DIAS computer model in providing insulin dose advice to patients with insulin dependent diabetes.
    Cavan DA; Hejlesen OK; Hovorka R; Evans JA; Metcalfe JA; Cavan ML; Halim M; Andreassen S; Carson ER; Sönksen PH
    Comput Methods Programs Biomed; 1998 May; 56(2):157-64. PubMed ID: 9700430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Run-to-run control of blood glucose concentrations for people with Type 1 diabetes mellitus.
    Owens C; Zisser H; Jovanovic L; Srinivasan B; Bonvin D; Doyle FJ
    IEEE Trans Biomed Eng; 2006 Jun; 53(6):996-1005. PubMed ID: 16761826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Personalized glucose-insulin model based on signal analysis.
    Goede SL; de Galan BE; Leow MKS
    J Theor Biol; 2017 Apr; 419():333-342. PubMed ID: 28039012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical validation of a new control-oriented model of insulin and glucose dynamics in subjects with type 1 diabetes.
    Fabietti PG; Canonico V; Orsini-Federici M; Sarti E; Massi-Benedetti M
    Diabetes Technol Ther; 2007 Aug; 9(4):327-38. PubMed ID: 17705688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifiability Analysis of Three Control-Oriented Models for Use in Artificial Pancreas Systems.
    Garcia-Tirado J; Zuluaga-Bedoya C; Breton MD
    J Diabetes Sci Technol; 2018 Sep; 12(5):937-952. PubMed ID: 30095007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased action of pulsatile compared to non-pulsatile insulin delivery during a meal-like glucose exposure simulated by computerized infusion in healthy humans.
    Juhl CB; Gjedsted J; Nielsen MF; Schmitz O
    Metabolism; 2012 Aug; 61(8):1177-81. PubMed ID: 22386942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adaptive bolus-based targeted glucose regulation of hyperglycaemia in critical care.
    Chase JG; Shaw GM; Lin J; Doran CV; Hann C; Robertson MB; Browne PM; Lotz T; Wake GC; Broughton B
    Med Eng Phys; 2005 Jan; 27(1):1-11. PubMed ID: 15603999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term diabetes blood glucose prediction based on blood glucose measurements.
    Ståhl F; Johansson R
    Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():291-4. PubMed ID: 19162650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Individualized therapy. Insulin therapy requirements in pregnancy and old age].
    MMW Fortschr Med; 2005 Nov; 147(46):61. PubMed ID: 16358639
    [No Abstract]   [Full Text] [Related]  

  • 36. [Inadequate blood glucose control with oral antidiabetic drugs. Early conversion to insulin].
    MMW Fortschr Med; 2002 Jul; 144(27-28):61. PubMed ID: 12198890
    [No Abstract]   [Full Text] [Related]  

  • 37. An improved PID switching control strategy for type 1 diabetes.
    Marchetti G; Barolo M; Jovanovic L; Zisser H; Seborg DE
    IEEE Trans Biomed Eng; 2008 Mar; 55(3):857-65. PubMed ID: 18334377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of insulin lispro in type 2 diabetes during closed-loop insulin delivery.
    Ruan Y; Thabit H; Kumareswaran K; Hovorka R
    Comput Methods Programs Biomed; 2014 Nov; 117(2):298-307. PubMed ID: 25092225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The rechargeable insulin injector, a beautiful evolution].
    Sauvanet JP
    Soins; 2007 Jun; (716):25-8. PubMed ID: 17718026
    [No Abstract]   [Full Text] [Related]  

  • 40. [Lispro mixed insulins in type 2 diabetes. Preventing postprandial insulin rise].
    MMW Fortschr Med; 2000 Jul; 142(28-29):58-9. PubMed ID: 10959169
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.